News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN)'s 'Miracle Pill,' Iressa Returns



5/20/2009 8:05:34 AM

Bookmark and Share

Forbes -- When AstraZeneca got U.S. clearance to sell the lung cancer-fighting pill Iressa in May 2003, it seemed to be a victory for patients and the company. Chief Executive Tom McKillop predicted the pill would become a "megabrand" with sales of more than $1 billion.


Read at Forbes


comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES